Global Primary Immunodeficiency Diseases Market US$ 6.

1 Billion by 2021

Primary immunodeficiency diseases or disorders (PIDD or PI) are caused as part of the body's immune system is
missing or does not function normally, such that it is an inherited flaw in the immune system that increases the
susceptibility to infections. Besides susceptibility to infections, PIDD may cause other health problems as well,
including allergies, asthma, swollen joints, digestive tract problems, growth problems or an enlarged liver and spleen.

The global primary immunodeficiency diseases market report estimates the market size in US$ million for 2014-
2021, and forecasts growth trends over a period of 2017-2021. The market for key market segments has been
estimated based on epidemiology approach considering patient diagnosis rates, patient treatment rate (IVIG/SCIG),
average cost of treatment by regions. The highlights of the report include global number of PID patients, by disease
(including subclasses), global number of patient population for treatment or therapy, global number of PID patients,
by 15 most commonly identified PIDs by region, and by country, and PID patients gender and age by global
comparative analysis. The global primary immunodeficiency disease (PIDD or PID or PI) market is dominated by North
America and Europe, collectively accounting for major share of the market in 2016. National PID registries
worldwide, increasing healthcare expenditure and government support are the major factors driving the global
primary immunodeficiency diseases market during the forecast period.

Browse Primary Immunodeficiency Diseases Market by Disease Type (Antibody Deficiency Agammaglobulinaemia,
Common Variable Immune Deficiency, IgG Subclass Deficiency, SIgAD; Cellular Immunodeficiency Ataxia
Telangiectasia, DiGeorge Syndrome, Hyper IgM Syndromes, Wiskott-Aldrich Syndrome; Innate Immune Disorders
Complement Deficiencies, and Hyper IgE Syndrome) and Test Type (Blood and Prenatal Testing), and Treatment Type
(Immunoglobulin Replacement Therapy, Antibiotics Therapy, Stem Cell and Gene Therapy) and Forecast 2017-2021
report at https://www.ihealthcareanalyst.com/report/primary-immunodeficiency-diseases-market/

The report also provides the detailed market landscape and profiles of major competitors in the global market
including company overview, financial snapshot, major products and services offered, and recent trends in
strategic management. The major companies profiled in the report include Baxter nternational, Inc., Bio Products
Laboratory, Biotest AG, CSL Behring LLC, Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, and others.

1. Disease Type
1.1. Antibody Deficiency
1.1.1. Agammaglobulinaemia
1.1.2. Common Variable Immune Deficiency
1.1.3. IgG Subclass Deficiency
1.1.4. Selective IgA Deficiency (SIgAD)
1.1.5. Others
1.2. Cellular Immunodeficiency
1.2.1. Ataxia Telangiectasia
1.2.2. DiGeorge Syndrome
1.2.3. Hyper IgM Syndromes
1.2.4. Wiskott-Aldrich Syndrome
1.2.5. Others
1.3. Innate Immune Disorder
1.3.1. Complement Deficiencies
1.3.2. Hyper IgE Syndrome
1.3.3. Others

2. Test Type
2.1. Blood Testing
2.2. Prenatal Testing
3. Treatment Type
3.1. Immunoglobulin Replacement Therapy
3.2. Antibiotics Therapy
3.3. Stem cell and Gene Therapy
3.4. Others

4. Geography (Region, Country)

4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World

5. Company Profiles
5.1. Baxter International, Inc.
5.2. Bio Products Laboratory
5.3. Biotest AG
5.4. CSL Behring LLC
5.5. Grifols S.A.
5.6. Kedrion S.p.A.
5.7. LFB S.A.
5.8. Octapharma AG

To request Table of Contents and Sample Pages of this report visit:

https://www.ihealthcareanalyst.com/report/primary-immunodeficiency-diseases-market/

About Us

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis,
and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting
grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics,
healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client
assignments targeted at clients specific business objectives, information needs, time frame and budget. Please
contact us to receive a proposal for a proprietary single-client study.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com